(
A) Alignments of EFR with human kinases containing oncogenic, kinase activating mutations that stabilize the αC-helix-in active-like conformation (described in
Foster et al., 2016;
Hu et al., 2015). Homologous sites in EFR are indicated by arrows with the residue number. (
B) Structural model of the EFR kinase domain from AlphaFold2 with homologous sites identified in the sequence alignment from A highlighted in teal (missense mutation) or red (deletion). EFR Y836 at the C-terminal end of the αE-helix is colored purple. (
C) Screening of the homology-based putatively activating EFR mutations for restoration of EFR
Y836F function in
N. benthamiana. All putative activating mutations were functional at WT-like level except EFR
ΔNLLKH. Only EFR
F761[H/M] could functionally recover EFR
Y836F as the oxidative burst was partially restored. (
D) EFR
L873E showed a WT-like oxidative burst but EFR
L873E/Y836F did not restore the oxidative burst. Outliers are in indicated by asterisk in addition to the outlier itself and are included in statistical analysis; Statistical test: Kruskal-Wallis test (p=9.319*10
–6 in C, p=0.01242 in D), Dunn’s post-hoc test with Benjamin-Hochberg correction (p ≤ 0.05) Groups with like lowercase letter designations are not statistically different.